Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung Cancer

PURPOSE: Development of new therapies for previously treated small-cell lung cancer (SCLC) is a major unmet need. Here, we describe a randomized, phase II trial of weekly topotecan with or without ziv-aflibercept (VEGF-trap) in this clinical setting. PATIENTS AND METHODS: Patients with previously tr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Allen, Jeffrey W., Moon, James, Redman, Mary, Gadgeel, Shirish M., Kelly, Karen, Mack, Philip C., Saba, Hanna M., Mohamed, Mohamed K., Jahanzeb, Mohammad, Gandara, David R.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2014
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121504/
https://ncbi.nlm.nih.gov/pubmed/25002722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.51.4109
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars